(Q22306351)

8 February 2023

33

Kenneth Dickstein

Kenneth

Dickstein

1 reference

8 February 2023

Juan Luis Tamargo

13

Juan Luis

Tamargo

1 reference

8 February 2023

Alice K Jacobs

16

Alice K

Jacobs

1 reference

8 February 2023

Marco Metra

36

Marco

Metra

1 reference

8 February 2023

19

Elliott M Antman

Elliott M

Antman

1 reference

8 February 2023

7

Jonathan L Halperin

Jonathan L

Halperin

1 reference

8 February 2023

15

Sidney C Smith

Sidney C Jr

Smith

1 reference

8 February 2023

Kenneth A. Ellenbogen

6

Kenneth A Ellenbogen

Kenneth A

Ellenbogen

1 reference

8 February 2023

25

Barbara Riegel

Barbara

Riegel

1 reference

8 February 2023

28

Andrzej Budaj

Andrzej

Budaj

1 reference

8 February 2023

8

Jean-Yves Le Heuzey

Jean-Yves

Le Heuzey

1 reference

8 February 2023

29

A John Camm

A John

Camm

1 reference

8 February 2023

Harry J. G. M. Crijns

4

Harry J Crijns

Harry J

Crijns

1 reference

8 February 2023

34

John Lekakis

John

Lekakis

1 reference

8 February 2023

12

Eric N Prystowsky

Eric N

Prystowsky

1 reference

8 February 2023

17

Cynthia D Adams

Cynthia D

Adams

1 reference

8 February 2023

23

Joseph P Ornato

Joseph P

Ornato

1 reference

8 February 2023

3

David S Cannom

David S

Cannom

1 reference

8 February 2023

14

Samuel Wann

Samuel

Wann

1 reference

8 February 2023

18

Jeffery L Anderson

Jeffery L

Anderson

1 reference

8 February 2023

22

Rick Nishimura

Rick

Nishimura

1 reference

8 February 2023

26

Silvia G Priori

Silvia G

Priori

1 reference

8 February 2023

31

Jaap W Deckers

Jaap W

Deckers

1 reference

8 February 2023

32

Catherine Despres

Catherine

Despres

1 reference

8 February 2023

35

Keith McGregor

Keith

McGregor

1 reference

8 February 2023

38

Ady Osterspey

Ady

Osterspey

1 reference

8 February 2023

40

José Luis Zamorano

José Luis

Zamorano

1 reference

8 February 2023

Lars E Rydén

2

Lars E

Rydén

1 reference

8 February 2023

Anne B Curtis

5

Anne B

Curtis

1 reference

8 February 2023

G Neal Kay

9

G Neal

Kay

1 reference

8 February 2023

James E Lowe

10

James E

Lowe

1 reference

8 February 2023

S Bertil Olsson

11

S Bertil

Olsson

1 reference

8 February 2023

Sharon Ann Hunt

21

Sharon Ann

Hunt

1 reference

8 February 2023

Richard L Page

24

Richard L

Page

1 reference

8 February 2023

Jean-Jacques Blanc

27

Jean-Jacques

Blanc

1 reference

8 February 2023

Veronica Dean

30

Veronica

Dean

1 reference

8 February 2023

Joao Morais

37

Joao

Morais

1 reference

8 February 2023

Jonathan L Halperin

Jonathan L

Halperin

20

1 reference

8 February 2023

Juan Luis Tamargo

Juan Luis

Tamargo

39

1 reference

Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials

8 February 2023

language of work or name

English

0 references

publication date

15 August 2006

0 references

published in

Circulation

0 references

volume

114

0 references

issue

7

0 references

page(s)

e257-e354

0 references

cites work

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mechanism of flutter and fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Arterial embolism in thyrotoxicosis with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone in the management of refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

COMPLICATIONS AND LIMITATIONS OF DIRECT-CURRENT COUNTERSHOCK

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Hypertrophic cardiomyopathy: a systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A multicenter risk index for atrial fibrillation after cardiac surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Obesity and the Risk of New-Onset Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Obesity and atrial fibrillation: is one epidemic feeding the other?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ximelagatran--promises and concerns

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prophylaxis against postoperative atrial fibrillation: current progress and future directions

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The optimal technique for electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The cardiac muscle in the pulmonary vein of the rat: A morphological and electrophysiological study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Expression and activity of ectopeptidases in fibrillating human atria

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mechanically induced potentials in atrial fibroblasts from rat hearts are sensitive to hypoxia/reoxygenation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Auricular fibrillation with aberration simulating ventricular paroxysmal tachycardia

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Experimental studies on auricular flutter and auricular fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrocardiographic and serum enzymic alterations associated with cardiac alterations induced in dogs by single transthoracic damped sinusoidal defibrillator shocks of various strengths

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Coronary heart disease and atrial fibrillation: the Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Treatment of arrhythmias during pregnancy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The use of quinidine in cardioversion.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Spread of excitation from the atrium into thoracic veins in human beings and dogs

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrical properties of the thoracic veins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Occult thyrotoxicosis: A correctable cause of “idiopathic” atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Alpha-receptor restriction of coronary blood flow during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of enalapril on ventricular arrhythmias in congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Factors predisposing to supraventricular tachyarrhythmias after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone for refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone for paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Treatment of atrial tachyarrhythmias and preexcitation syndrome with flecainide acetate

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of intravenous propafenone for the acute management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Myocardial release of hypoxanthine and lactate during percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of pregnancy on pressure gradient in mitral stenosis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrode pad size, transthoracic impedance and success of external ventricular defibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of flecainide on the atrial defibrillation threshold

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Safety and efficacy of in-office cardioversion for treatment of supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Role of concealed and supernormal conductions during atrial fibrillation in the preexcitation syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Human experience with amiodarone in the embryonic period

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pregnancy outcome after gestational exposure to amiodarone in Canada

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Hazards of postoperative atrial arrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Accepted, controversial, and speculative aspects of ventricular defibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone in pregnancy. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antiarrhythmic effect of converting enzyme inhibitors in congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Chemical cardioversion of atrial fibrillation with intravenous dofetilide

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Predictors of ischemic stroke in non-rheumatic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

High energy transcatheter cardioversion of chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of right ventricular pacing on ventricular rhythm during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increased intracardiovascular clotting in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: Endocrinologic silence

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Coagulation activity is increased in the left atrium of patients with mitral stenosis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pharmacology of cardiac potassium channels.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Female preponderance in ibutilide-induced torsade de pointes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardi

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Postoperative atrial fibrillation and mortality after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrophysiologic and electroanatomic changes in the human atrium associated with age.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial stunning: determinants and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cost of care distribution in atrial fibrillation patients: the COCAF study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Coadministration of flecainide acetate and sotalol during pregnancy: Lack of teratogenic effects, passage across the placenta, and excretion in human breast milk

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Sotalol: An important new antiarrhythmic

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Management of atrial fibrillation: therapeutic options and clinical decisions

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Initial energy for elective external cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk of stroke in patients with atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of diltiazem on the recurrence rate of paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial size and function after spontaneous cardioversion of atrial fibrillation and their relation to N-terminal atrial natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk of thromboembolism in chronic atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of amiodarone for the termination of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mexiletine use in pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Molecular mechanisms of remodeling in human atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrical, contractile and structural remodeling during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transthoracic impedance to defibrillator discharge. Effect of electrode size and electrode-chest wall interface

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Multiplane transesophageal echocardiography: image orientation, examination technique, anatomic correlations, and clinical applications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation: strategies to control, combat, and cure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Controlled trial of sotalol for one year after myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk of stroke in non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis in sinus rhythm: relationship to mitral valve and left atrial measurements.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Dronedarone for prevention of atrial fibrillation: a dose-ranging study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pharmacological rate control of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Rate versus rhythm control in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Advances in the surgical treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prolonged fractionation of paced right atrial electrograms in patients with atrial flutter and fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Genomic medicine and atrial fibrillation**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Familial atrial fibrillation is a genetically heterogeneous disorder.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Obliteration of the left atrial appendage for prevention of thromboembolism

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Autonomic modulation preceding the onset of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Improving survival for patients with atrial fibrillation and advanced heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Adverse effects of low dose amiodarone: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Thromboembolism in chronic atrial flutter: is the risk underestimated?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevention of postoperative atrial fibrillation: what is the best approach?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Myocardial cell death in fibrillating and dilated human right atria.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Echocardiographic assessment of the left atrial appendage

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A differential effect of aspirin on prevention of stroke in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Selective atrionodal input ablation for induction of proximal complete heart block with stable junctional escape rhythm in patients with uncontrolled atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pulmonary vein as an ectopic focus in digitalis-induced arrhythmia

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

New ideas about atrial fibrillation 50 years on.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antiarrhythmic effects of intravenous timolol in supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cerebral blood flow before and after cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Rate versus rhythm control in the management of patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical outcome of patients who develop PAF after CABG surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

New antiarrhythmic drugs for the treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transient proarrhythmic state following atrioventricular junctional radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Relation of age and sex to atrial electrophysiological properties in patients with no history of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Beta-blocker therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Nonpulmonary vein foci: do they exist?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Stroke risk in an elderly population with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Recent advances in drug therapy for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of verapamil on immediate recurrence of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Paroxysmal cycle length shortening in the pulmonary veins during atrial fibrillation correlates with arrhythmogenic triggering foci in sinus rhythm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Extended distribution of prolonged and fractionated right atrial electrograms predicts development of chronic atrial fibrillation in patients with idiopathic paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

New Cryotechnology for Electrical Isolation of the Pulmonary Veins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reentrant tachycardia in pulmonary veins of patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Progress in nonpharmacologic therapy of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Common left pulmonary vein: a consistent source of arrhythmogenic atrial ectopy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardiac surgery for arrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Percutaneous left atrial appendage transcatheter occlusion: an effective and safe protection against stroke or embolism?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left Atrial-Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The who, what, why, and how-to guide for circumferential pulmonary vein ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Techniques for curative treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Serum troponins T and I after elective cardioversion

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines a

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Dispersion of atrial repolarization in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

β-Blockers are effective in congestive heart failure patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

"Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

1 reference

7 January 2021

Elective Cardioversion: Influence of Paddle-Electrode Location and Size on Success Rates and Energy Requirements

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The natural history of lone atrial fibrillation. A population-based study over three decades

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The heart in hypertension

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Identification of a genetic locus for familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ventricular pacing or dual-chamber pacing for sinus-node dysfunction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Warfarin, aspirin, or both after myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Catheter ablation for atrial fibrillation in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone versus sotalol for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Circumferential pulmonary-vein ablation for chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Predicting the risk of atrial fibrillation after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of flecainide and procainamide in cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Improved control of atrial fibrillation with combined pindolol and digoxin therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transthoracic echo/Doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

An 8 1/2-year clinical experience with surgery for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Classification system of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Fibrosis and hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrophysiologic characterization of dronedarone in guinea pig ventricular cells

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Rising rates of hospital admissions for atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Direct current countershock complications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation and arterial embolism in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Occurrence of Atrial Fibrillation in Patients With Paroxysmal Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A Comparison of Intravenous Propafenone and Flecainide in the Treatment of Tachycardias Associated with the Wolff-Parkinson-White Syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome: current perspectives

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Internal atrial defibrillation: effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Factors predisposing to the development of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrioventricular node reentry: physiology and radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Unmasking effect of propafenone on the concealed form of the Brugada phenomenon

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of biphasic shock for transthoracic cardioversion of persistent atrial fibrillation: can we predict energy requirements?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Paroxysmal atrial fibrillation: a need for classification

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Immediate reinitiation of atrial fibrillation following internal atrial defibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of electrode length on atrial defibrillation thresholds

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Right atrial focal atrial fibrillation: electrophysiologic characteristics and radiofrequency catheter ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Spontaneous echo contrast: where there's smoke there's fire

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea‐pig

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

KCNQ1 gain-of-function mutation in familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Arterial embolism in thyrotoxicosis with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term results of DC reversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Extreme tachycardia complicating the use of disopyramide in atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

What is meant by a "controlled" ventricular rate in atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Hypercoagulability and haemodynamic abnormalities in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Autonomic tone variations before the onset of paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Locus for atrial fibrillation maps to chromosome 6q14-16

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Electrical Remodeling of the Atria in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Inflammation as a risk factor for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation originating from persistent left superior vena cava

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Beneficial cardiovascular pleiotropic effects of statins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Association of atrial fibrillation and obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Fish intake and risk of incident atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

OBSERVATIONS ON THE VENTRICULAR DYSRHYTHMIA ASSOCIATED WITH ATRIAL FIBRILLATION IN THE DOG HEART

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardioversion and Digitalis Drugs: Changed Threshold to Electric Shock in Digitalized Animals

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Obesity and risk of new-onset atrial fibrillation after cardiac surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrillation after transthoracic cardioversion.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: the Lausanne Stroke Registry.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Myocardial sarcoidosis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Clinical course of recent-onset atrial fibrillation treated with oral propafenone

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of antithrombotic agents during pregnancy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial mechanical performance following internal and external cardioversion of atrial fibrillation: its relationship to peripheral embolization and acute cerebrovascular accident

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Lengthening of intraatrial conduction time in atrial fibrillation and its relation with early recurrence of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Pharmacological Approaches in the Treatment of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Detection and characterization of intracardiac thrombi on MR imaging

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Relation of left atrial pathology to atrial fibrillation in mitral valvular disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

Safety of Electrical Cardioversion in Patients Without Digitalis Toxicity

1 reference

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.106.177292

7 January 2021

10.1161/CIRCULATIONAHA.106.177292

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017